Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Natural History Study to Assess the Occurrence of HPA-1a Alloimmunization in Women Identified at Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT05345561 is registered in ClinicalTrials.gov with Rallybio as lead sponsor.

NCT NCT05345561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05345561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Natural History Study to Assess the Occurrence of HPA-1a Alloimmunization in Women Identified at Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Lead sponsor
Rallybio
Phase
Observational
Overall status
Completed
Start date
March 14, 2022
Completion date
October 10, 2025
Enrollment
14,390 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

fetal and neonatal alloimmune thrombocytopenia